Preferred initial diagnostic panel for skin and mucous membrane disorders that present with blistering, erosions, eczema, pruritus, and/or urticaria from suspected basement membrane zone antibody-associated disease (eg, bullous pemphigoid, pemphigoid variants, epidermolysis bullosa acquisita, linear IgA bullous dermatosis, and linear IgA disease variants). Order concurrently with Cutaneous Direct Immunofluorescence, Biopsy (0092572) for initial diagnosis. Use for disease monitoring with semiquantitative antibody assessments and tracking.
Indirect Fluorescent Antibody/Enzyme-Linked Immunosorbent Assay
Plain Red or Serum Separator Tube (SST).
Transfer 2 mL serum to an ARUP Standard Transport Tube. (Min: 0.5 mL)
Hemolyzed or Lipemic specimens. Plasma
Ambient: 1 week; Refrigerated: 2 weeks; Frozen: Indefinitely
Refer to report
No compliance statements are in use for this test.
For specimens less than 0.5 mL, call the Immunodermatology Laboratory at (866) 266-5699.
88346; 88350 x2; 83516 x3
|Component Test Code*||Component Chart Name||LOINC|
|3001664||Basement Membrane Zone Ab Panel|
|3001667||EER Basement Membrane Zone Ab Panel|